Wakamoto Pharmaceutical Co. Ltd. | Ownership
Companies that own Wakamoto Pharmaceutical Co. Ltd.
Nomura Asset Management Co., Ltd.
402,700
1.15%
5,900
0%
07/31/2018
Nikko Asset Management Co., Ltd.
193,598
0.56%
-2
0%
08/20/2018
Daiwa Asset Management Co. Ltd.
186,600
0.54%
3,500
0%
07/31/2018
Dimensional Fund Advisors LP
129,500
0.37%
4,500
0%
04/30/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
77,403
0.22%
1,503
0%
07/31/2018
Asset Management One Co., Ltd.
21,400
0.06%
-600
0%
04/20/2018
Sumitomo Mitsui Trust Asset Management Co., Ltd.
19,000
0.06%
-999
0%
12/11/2017
Lyxor International Asset Management SAS
8,847
0.03%
90
0%
09/05/2018
State Street Global Advisors (Japan) Co. Ltd.
7,000
0.02%
0
0%
03/06/2017
DFA Australia Ltd.
6,048
0.02%
17
0%
11/30/2017
| Address |
2-2-2 Nihonbashi Hon-cho
Tokyo Tokyo 103
Japan
|
|
Employees
|
- |
| Website |
http://www.wakamoto-pharm.co.jp |
| Updated |
07/08/2019 |
| Wakamoto Pharmaceutical Co., Ltd. engages in the manufacture and sale of ethical and non-prescription drugs. Its operations are carried out through the following segments: Medicine, Non-Prescription Drugs, Special Sales and Others. The Medicine segment provides ethical drugs. |
